Back
ENGIE Brasil Energia SA Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
42
EGIEY
ENGIE Brasil Energia SA
Last Price:
$6.64
Seasonality Move:
3.49%
Sell
33
ALNY
Alnylam Pharmaceuticals
Last Price:
$266.84
Seasonality Move:
7.6%
Sell
42
ENGIE Brasil Energia SA (EGIEY)
is a Sell
Is ENGIE Brasil Energia SA a Buy, Sell or Hold?
-
The current ENGIE Brasil Energia SA [EGIEY] share price is $6.83. The Score for EGIEY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
EGIEY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $255.76. The Score for ALNY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EGIEY Stock Price Chart
What is ENGIE Brasil Energia SA's stock price today?
-
The ENGIE Brasil Energia SA share price today is $6.83The current trend is relatively stagnant and EGIEY is experiencing slight selling pressure.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $255.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
EGIEY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.9 | Buy |
Relative Strength Index (14 RSI): | 53.98 | Buy |
Chaikin Money Flow: | -680 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.44 - 6.9) | Buy |
Bollinger Bands (100): | (6.01 - 6.77) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.17 | Buy |
Relative Strength Index (14 RSI): | 47.81 | Sell |
Chaikin Money Flow: | -809168 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (239.46 - 269.34) | Buy |
Bollinger Bands (100): | (240.63 - 269.83) | Buy |
EGIEY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.85 | Sell |
20-day SMA: | 6.73 | Buy |
50-day SMA: | 6.51 | Buy |
200-day SMA: | 7.17 | Sell |
8-day EMA: | 6.12 | Buy |
20-day EMA: | 4.07 | Buy |
50-day EMA: | 2.07 | Buy |
200-day EMA: | 0.59 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 273.68 | Sell |
20-day SMA: | 257.17 | Sell |
50-day SMA: | 260.57 | Sell |
200-day SMA: | 255.06 | Buy |
8-day EMA: | 266.02 | Sell |
20-day EMA: | 261.54 | Sell |
50-day EMA: | 258.26 | Sell |
200-day EMA: | 244.93 | Buy |
ENGIE Brasil Energia SA Earnings Growth & EGIEY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.06 per share, an increase this year of $1.07 per share, and an increase next year of $2.78 per share.
ENGIE Brasil Energia SA Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |